| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Allosteric modulation of monoamine transporters – new drug targets in depression
|
Sanchez, Connie
|
|
2006
|
3 |
4 |
p. 483-488
6 p.
|
article
|
| 2 |
Anti-obesity pharmacotherapy: Future perspectives utilising 5-HT2C receptor agonists
|
Dutton, Alice C.
|
|
2006
|
3 |
4 |
p. 577-583
7 p.
|
article
|
| 3 |
A role for melanocortin agonists in treating male and female sexual dysfunction
|
Shadiack, Annette M.
|
|
2006
|
3 |
4 |
p. 605-611
7 p.
|
article
|
| 4 |
Benzodiazepine receptor agonists and insomnia: Is subtype selectivity lost in translation?
|
Ebert, Bjarke
|
|
2006
|
3 |
4 |
p. 547-554
8 p.
|
article
|
| 5 |
CGRP receptor antagonists: A new frontier of anti-migraine medications
|
de Prado, Blanca Marquez
|
|
2006
|
3 |
4 |
p. 593-597
5 p.
|
article
|
| 6 |
Contents
|
|
|
2006
|
3 |
4 |
p. i-ii
nvt p.
|
article
|
| 7 |
Countering core and co-morbid symptoms of affective disorders: Complementary multi-target strategies
|
Millan, Mark J.
|
|
2006
|
3 |
4 |
p. 457-465
9 p.
|
article
|
| 8 |
Developing selectively nonselective drugs for treating CNS disorders
|
Gray, John A.
|
|
2006
|
3 |
4 |
p. 413-419
7 p.
|
article
|
| 9 |
Development of functionally selective agonists as novel therapeutic agents
|
Berg, Kelly A.
|
|
2006
|
3 |
4 |
p. 421-428
8 p.
|
article
|
| 10 |
Dopamine D4 receptors and the regulation of penile erection
|
Brioni, Jorge D.
|
|
2006
|
3 |
4 |
p. 599-604
6 p.
|
article
|
| 11 |
Emerging pharmacotherapeutic strategies for the treatment of ischemic stroke
|
Culmsee, Carsten
|
|
2006
|
3 |
4 |
p. 621-628
8 p.
|
article
|
| 12 |
Endocannabinoids and their receptors as targets for treating metabolic and psychiatric disorders
|
Felder, Christian C.
|
|
2006
|
3 |
4 |
p. 561-567
7 p.
|
article
|
| 13 |
Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action
|
Du, Jing
|
|
2006
|
3 |
4 |
p. 519-526
8 p.
|
article
|
| 14 |
GABAA receptor modulators as anxioselective anxiolytics
|
Basile, Anthony S.
|
|
2006
|
3 |
4 |
p. 475-481
7 p.
|
article
|
| 15 |
Glutamate transport inhibitors as targets for treating psychosis
|
Dunlop, John
|
|
2006
|
3 |
4 |
p. 533-537
5 p.
|
article
|
| 16 |
Glycine transporter inhibitors as novel antipsychotics
|
Thomsen, Christian
|
|
2006
|
3 |
4 |
p. 539-545
7 p.
|
article
|
| 17 |
Heterodimers of G protein-coupled receptors as novel and distinct drug targets
|
Rozenfeld, Raphael
|
|
2006
|
3 |
4 |
p. 437-443
7 p.
|
article
|
| 18 |
In-Target versus Off-Target allosteric modulators of GPCRs
|
Ballesteros, Juan
|
|
2006
|
3 |
4 |
p. 445-450
6 p.
|
article
|
| 19 |
Metabotropic glutamate receptor targets for neuropsychiatric disorders
|
Linden, Anni-Maija
|
|
2006
|
3 |
4 |
p. 507-517
11 p.
|
article
|
| 20 |
Nervous system disorders
|
Altar, C. Anthony
|
|
2006
|
3 |
4 |
p. 411-412
2 p.
|
article
|
| 21 |
Neurogenesis: What is its role in the cause and cure of depression?
|
Henn, Fritz A.
|
|
2006
|
3 |
4 |
p. 503-506
4 p.
|
article
|
| 22 |
NK3 receptor antagonists for the treatment of schizophrenia
|
Meltzer, Herbert
|
|
2006
|
3 |
4 |
p. 555-560
6 p.
|
article
|
| 23 |
Novel mechanisms to treat depression and anxiety: Will neuropeptide antagonists succeed?
|
Gerald, Christophe P.G.
|
|
2006
|
3 |
4 |
p. 467-473
7 p.
|
article
|
| 24 |
Partial agonism of dopamine, serotonin and opiate receptors for psychiatry
|
Yocca, Frank
|
|
2006
|
3 |
4 |
p. 429-435
7 p.
|
article
|
| 25 |
RNA interference as a therapeutic strategy for treating CNS disorders
|
Hoyer, Daniel
|
|
2006
|
3 |
4 |
p. 451-456
6 p.
|
article
|
| 26 |
Targeting glycogen synthase kinase-3 in Alzheimer's disease
|
Huang, Hui-Chuan
|
|
2006
|
3 |
4 |
p. 613-619
7 p.
|
article
|
| 27 |
Targeting melanocortin receptors for the treatment of obesity
|
Markison, Stacy
|
|
2006
|
3 |
4 |
p. 569-576
8 p.
|
article
|
| 28 |
Treating neuropsychiatric disorders with PDE10A inhibitors
|
Siuciak, Judith A.
|
|
2006
|
3 |
4 |
p. 527-532
6 p.
|
article
|
| 29 |
Triple reuptake inhibitors as antidepressants
|
Skolnick, Phil
|
|
2006
|
3 |
4 |
p. 489-494
6 p.
|
article
|
| 30 |
Unraveling the complexities of neurogenesis to guide development of CNS therapeutics
|
Morse, Andrew C.
|
|
2006
|
3 |
4 |
p. 495-501
7 p.
|
article
|
| 31 |
Voltage-gated sodium channels in spinal ganglia: Tempting targets for new pain medications
|
Gribkoff, Valentin K.
|
|
2006
|
3 |
4 |
p. 585-591
7 p.
|
article
|
Journal description